Clinical Advances and Management in Corneal Diseases

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".

Deadline for manuscript submissions: 25 March 2025 | Viewed by 324

Special Issue Editor


E-Mail Website
Guest Editor
Department of Ophthalmology, University of Tokyo Hospital, Tokyo, Japan
Interests: cornea; refractive surgery; corneal transplantation; corneal dystrophy

Special Issue Information

Dear Colleagues,

We are delighted to announce the launch of our upcoming Special Issue. Recently, many innovative technologies have been developed to advance the treatment of corneal diseases. However, some diseases are still hard to control. This Special Issue, entitled "Clinical Advances and Management in Corneal Diseases", aims to focus on the latest developments in the diagnosis, treatment, and management of corneal disorders. We aim to cover a range of topics, including innovative surgical techniques, such as advanced keratoplasty methods and the use of regenerative medicine in corneal transplantation. Additionally, we set out to explore authentic therapeutic approaches, including pharmacological treatments and surgery, aimed at improving patient outcomes. In this Special Issue, we welcome the submission of papers focused on the diagnosis, treatment, and management of corneal diseases.

Dr. Yukako Taketani
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • refractive surgery
  • corneal transplantation
  • regenerative medicine
  • AI diagnosis
  • infectious disease
  • corneal dystrophy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 3169 KiB  
Article
Experimental Study on Ocular Surface Protection by Soft Contact Lenses Due to Volcanic Ash Exposure
by Hiroshi Toshida, Yusuke Matsuzaki and Masahiro Miyazaki
J. Clin. Med. 2024, 13(17), 5281; https://doi.org/10.3390/jcm13175281 - 6 Sep 2024
Viewed by 172
Abstract
Background: Sudden volcanic eruptions can lead to volcanic ash entering the eyes, causing severe discomfort and complicating evacuation efforts. The specific effects of volcanic ash on ocular tissues, especially when wearing soft contact lenses (SCLs), are not well documented, prompting this experimental [...] Read more.
Background: Sudden volcanic eruptions can lead to volcanic ash entering the eyes, causing severe discomfort and complicating evacuation efforts. The specific effects of volcanic ash on ocular tissues, especially when wearing soft contact lenses (SCLs), are not well documented, prompting this experimental investigation. Methods: White rabbits with normal eyes were randomly divided into three groups: (1) a bare eye group: bare eye + volcanic ash exposure + eye washing, (2) an SCL group: SCL-wearing eye + volcanic ash exposure + eye washing, and (3) a control group: eye washing only. In groups 1 and 2, volcanic ash was applied to one eye under topical anesthesia, followed by immediate saline rinsing. Slit-lamp microscopy and histopathological analysis were conducted after euthanasia. Results: Slit-lamp and histopathological examinations revealed more significant corneal and conjunctival erosion in the bare eye group compared to the SCL group, which showed limited damage. The control group displayed no ocular damage. Conclusions: Guidelines from the “Volcanic Ash Health Effects: A Guide for the Public” by the National Research Institute for Earth Science and Disaster Resilience recommend removing SCLs during ashfall. Our findings suggest that the damage to the corneal and conjunctival epithelium is less severe in SCL-wearing eyes than in bare eyes, recommending that SCL wearers prioritize evacuation over lens removal during sudden ashfall. Full article
(This article belongs to the Special Issue Clinical Advances and Management in Corneal Diseases)
Show Figures

Figure 1

Back to TopTop